31 May 2023FeaturesPatentsJamie Atkins​ and Abi Heath

Enlarged Board of Appeal tackles entitlement to priority

It is certainly an exciting time at the EPO—barely two months have passed since the long awaited “plausibility” decision ( G 2/21), and the EPO Enlarged Board of Appeal (EBA) has just held oral proceedings to help it decide on another highly anticipated referral—this time on legal entitlement to priority ( G 1/22 and G 2/22).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at

More on this story

27 June 2023   An EPO Board of Appeal finding could be construed as loosening the requirements for establishing novelty, explains Jonathan Foster and James Clegg.
18 July 2023   Side letter to CPTPP agreement allows UK to opt-out of grace period for patents | No new action required on pharmaceutical patents or GIs.
25 July 2023   Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.